21 Jul 2020

We are pleased to share the results of the survey into the impact of Covid-19 on people with rare and less common cancers. The report is available here.

We had a fantastic response - over 1,400 respondents across the UK, with over 1,000 respondents in England. This repo...

8 Jul 2020

Cancer care was disrupted during the initial days of the Covid-19 pandemic but now services are up and running.  But cancer patients are worried about attending. So Cancer52 has created a video Cancer patients talk about their care to encourage patients to attend treat...

14 Jan 2020

The first quarterly All Member Meeting of 2020 is taking place on Wednesday 22nd January 2020, from 10am to 1pm in the Allen Room at St Anne's Soho.

Final agenda can be found here. The speakers are confirmed as:

  • Dave Chapman from the ACE team at CRUK for an upda...

29 Oct 2019

Rapid Diagnostic Centres (RDCs) and the roll out of personalised care are cornerstones of the implementation plans for Cancer Alliances in delivering the NHS Long Term Plan.

RDCs are of particular significance to rare and less common cancers because of their initial f...

18 Oct 2019

The annual All Stakeholder Briefing was a great success and we had a good turnout of both member organisations and pharmaceutical companies. 

David Fitzgerald, Cancer Programme Director at NHS England, presented an update on the NHS Long Term Plan, explaining tha...

12 Jul 2019

The All Members meeting was a very informative and enjoyable session, which featured a mix of great speakers. 

Jennifer Mitchell and Laura Thomas from Brighter Together who are our policy advisers presented on what our recent members survey on where we are now with the...

10 Jul 2019

On Wednesday 10th July we launched a new report, ‘Getting a better deal for people with rare and less common cancers: what we can learn from patients’ at an event for MPs at Portcullis House, Houses of Parliament. 

The report was based on a patient survey conducted in 2...

24 Jun 2019

Cancer52 held a roundtable on 4th April 2019 to explore the implications of the NHS Long Term Plan and what it means for rare and less common cancers.

Following opening remarks from Jane Lyons, Chair, and David Fitzgerald, NHS England, attendees discussed three question...

Please reload

  • Twitter
  • Facebook

Terms & conditions  Cookie policy   Privacy policy

Copyright © Cancer52. All rights reserved.

Cancer52 is registered as a charity in England and Wales (1174569) and a company limited by guarantee in England and Wales (7994413)